Advertisement

Index by author

October 01, 1999; Volume 27,Issue 10

A

  1. Abe, Tomio

    1. Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

  2. Aldridge, Susanna L. K.

    1. Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;

  3. Andersson, Tommy B.

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

  4. Appleton, Scott D.

    1. Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

B

  1. Bäckman, Assar

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

  2. Balis, Frank M.

    1. 2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition
      Jeri S. Roth, Cynthia M. McCully, Frank M. Balis, David G. Poplack and James A. Kelley
      Drug Metabolism and Disposition October 1999, 27 (10) 1128-1132;

  3. Berg, Mikael

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

  4. Bergh, Jonas

    1. Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;

  5. Beschke, K.

    1. Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
      T. Ebner, G. Heinzel, A. Prox, K. Beschke and H. Wachsmuth
      Drug Metabolism and Disposition October 1999, 27 (10) 1143-1149;

  6. Bolten, Suzanne

    1. Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;

  7. Brien, James F.

    1. Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

  8. Burton, Earl G.

    1. Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;

C

  1. Cao, Ling

    1. Induction of Rat Small Intestinal Cytochrome P-450 2J4
      Qing-Yu Zhang, Xinxin Ding, Deborah Dunbar, Ling Cao and Laurence S. Kaminsky
      Drug Metabolism and Disposition October 1999, 27 (10) 1123-1127;

  2. Cerniglia, Carl E.

    1. Biotransformation of Doxepin by Cunninghamella elegans
      Joanna D. Moody, James P. Freeman and Carl E. Cerniglia
      Drug Metabolism and Disposition October 1999, 27 (10) 1157-1164;

  3. Chen, I-Wu

    1. Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;

  4. Cheng, Ziqiang

    1. Studies on the Substrate Specificity of Human Intestinal UDP-Glucuronosyltransferases 1A8 and 1A10
      Ziqiang Cheng, Anna Radominska-Pandya and Thomas R. Tephly
      Drug Metabolism and Disposition October 1999, 27 (10) 1165-1170;

  5. Chiba, Kan

    1. Isoform-Selective Metabolism of Mianserin by Cytochrome P-450 2D
      Toshio Chow, Toyoko Hiroi, Susumu Imaoka, Kan Chiba and Yoshihiko Funae
      Drug Metabolism and Disposition October 1999, 27 (10) 1200-1204;

  6. Chiba, Masato

    1. Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;

  7. Chow, Toshio

    1. Isoform-Selective Metabolism of Mianserin by Cytochrome P-450 2D
      Toshio Chow, Toyoko Hiroi, Susumu Imaoka, Kan Chiba and Yoshihiko Funae
      Drug Metabolism and Disposition October 1999, 27 (10) 1200-1204;

  8. Chretien, Marc L.

    1. Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

  9. Clayton, Eddie

    1. Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;

D

  1. deLuna, Florencia A.

    1. Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;

  2. Diaz, Gonzalo J.

    1. Identification of Phase I Metabolites of 3-Methylindole Produced by Pig Liver Microsomes
      Gonzalo J. Diaz, Konstantine W. Skordos, Garold S. Yost and E. James Squires
      Drug Metabolism and Disposition October 1999, 27 (10) 1150-1156;

  3. Ding, Xinxin

    1. Induction of Rat Small Intestinal Cytochrome P-450 2J4
      Qing-Yu Zhang, Xinxin Ding, Deborah Dunbar, Ling Cao and Laurence S. Kaminsky
      Drug Metabolism and Disposition October 1999, 27 (10) 1123-1127;

  4. Dorko, Kenneth

    1. Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;

  5. Dunbar, Deborah

    1. Induction of Rat Small Intestinal Cytochrome P-450 2J4
      Qing-Yu Zhang, Xinxin Ding, Deborah Dunbar, Ling Cao and Laurence S. Kaminsky
      Drug Metabolism and Disposition October 1999, 27 (10) 1123-1127;

E

  1. Ebner, T.

    1. Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
      T. Ebner, G. Heinzel, A. Prox, K. Beschke and H. Wachsmuth
      Drug Metabolism and Disposition October 1999, 27 (10) 1143-1149;

  2. Echizen, Hirotoshi

    1. Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

  3. Edlund, Anders

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

  4. Engel, Leslie

    1. Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;

  5. Esplen, James E.

    1. Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;

F

  1. Freeman, James P.

    1. Biotransformation of Doxepin by Cunninghamella elegans
      Joanna D. Moody, James P. Freeman and Carl E. Cerniglia
      Drug Metabolism and Disposition October 1999, 27 (10) 1157-1164;

  2. Freijs, Agneta

    1. Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;

  3. Funae, Yoshihiko

    1. Isoform-Selective Metabolism of Mianserin by Cytochrome P-450 2D
      Toshio Chow, Toyoko Hiroi, Susumu Imaoka, Kan Chiba and Yoshihiko Funae
      Drug Metabolism and Disposition October 1999, 27 (10) 1200-1204;

H

  1. Haehner, Barbara

    1. Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;

  2. Hallström, Gösta

    1. Mass Balance and Metabolism of [3H]Formoterol in Healthy Men after Combined i.v. and Oral Administration–Mimicking Inhalation
      Johan Rosenborg, Per Larsson, Kerstin Tegnér and Gösta Hallström
      Drug Metabolism and Disposition October 1999, 27 (10) 1104-1116;

  3. Hansen, Kristian

    1. Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;

  4. Heinzel, G.

    1. Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
      T. Ebner, G. Heinzel, A. Prox, K. Beschke and H. Wachsmuth
      Drug Metabolism and Disposition October 1999, 27 (10) 1143-1149;

  5. Hiroi, Toyoko

    1. Isoform-Selective Metabolism of Mianserin by Cytochrome P-450 2D
      Toshio Chow, Toyoko Hiroi, Susumu Imaoka, Kan Chiba and Yoshihiko Funae
      Drug Metabolism and Disposition October 1999, 27 (10) 1200-1204;

I

  1. Imaoka, Susumu

    1. Isoform-Selective Metabolism of Mianserin by Cytochrome P-450 2D
      Toshio Chow, Toyoko Hiroi, Susumu Imaoka, Kan Chiba and Yoshihiko Funae
      Drug Metabolism and Disposition October 1999, 27 (10) 1200-1204;

  2. Iwade, Kazunori

    1. Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

J

  1. Jacobsen, Petter Balke

    1. Biotransformation of Nonionic X-Ray Contrast Agents In Vivo and In Vitro
      Petter Balke Jacobsen, Åsmund Larsen, Roozbeh Konarboland and Tore Skotland
      Drug Metabolism and Disposition October 1999, 27 (10) 1205-1213;

  2. Johansson, Thore

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

  3. Jonsson, Eva

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

  4. Jönsson, Marie

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

K

  1. Kaminsky, Laurence S.

    1. Induction of Rat Small Intestinal Cytochrome P-450 2J4
      Qing-Yu Zhang, Xinxin Ding, Deborah Dunbar, Ling Cao and Laurence S. Kaminsky
      Drug Metabolism and Disposition October 1999, 27 (10) 1123-1127;

  2. Karlsson, Mats O.

    1. Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;

  3. Kashima, Toshitaka

    1. Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

  4. Kelley, James A.

    1. 2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition
      Jeri S. Roth, Cynthia M. McCully, Frank M. Balis, David G. Poplack and James A. Kelley
      Drug Metabolism and Disposition October 1999, 27 (10) 1128-1132;

  5. Kimura, Sosuke

    1. Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

  6. Komoroski, Bernard J.

    1. Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;

  7. Konarboland, Roozbeh

    1. Biotransformation of Nonionic X-Ray Contrast Agents In Vivo and In Vitro
      Petter Balke Jacobsen, Åsmund Larsen, Roozbeh Konarboland and Tore Skotland
      Drug Metabolism and Disposition October 1999, 27 (10) 1205-1213;

  8. Kostrubsky, Vsevolod E.

    1. Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;

L

  1. Larsen, Åsmund

    1. Biotransformation of Nonionic X-Ray Contrast Agents In Vivo and In Vitro
      Petter Balke Jacobsen, Åsmund Larsen, Roozbeh Konarboland and Tore Skotland
      Drug Metabolism and Disposition October 1999, 27 (10) 1205-1213;

  2. Larsson, Per

    1. Mass Balance and Metabolism of [3H]Formoterol in Healthy Men after Combined i.v. and Oral Administration–Mimicking Inhalation
      Johan Rosenborg, Per Larsson, Kerstin Tegnér and Gösta Hallström
      Drug Metabolism and Disposition October 1999, 27 (10) 1104-1116;

  3. Larsson, Rolf

    1. Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;

  4. Leidvik, Brith

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

  5. Lin, Jiunn H.

    1. Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;

  6. Lin, Yuh J.

    1. Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;

  7. Lindon, John C.

    1. Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;

M

  1. Marks, Gerald S.

    1. Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

  2. Masimirembwa, Collen M.

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

  3. Maurice, Donald H.

    1. Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

  4. Maziasz, Timothy J.

    1. Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;

  5. McCully, Cynthia M.

    1. 2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition
      Jeri S. Roth, Cynthia M. McCully, Frank M. Balis, David G. Poplack and James A. Kelley
      Drug Metabolism and Disposition October 1999, 27 (10) 1128-1132;

  6. McLaughlin, Brian E.

    1. Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

  7. Molnar, Valeria

    1. Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;

  8. Moody, Joanna D.

    1. Biotransformation of Doxepin by Cunninghamella elegans
      Joanna D. Moody, James P. Freeman and Carl E. Cerniglia
      Drug Metabolism and Disposition October 1999, 27 (10) 1157-1164;

  9. Murata, Noboru

    1. Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

N

  1. Nakatsu, Kanji

    1. Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

  2. Nicholson, Jeremy K.

    1. Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;

  3. Nishime, Joy A.

    1. Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;

  4. Nygren, Peter

    1. Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;

O

  1. Otter, Charlotta

    1. Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

P

  1. Paulson, Susan K.

    1. Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;

  2. Poplack, David G.

    1. 2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition
      Jeri S. Roth, Cynthia M. McCully, Frank M. Balis, David G. Poplack and James A. Kelley
      Drug Metabolism and Disposition October 1999, 27 (10) 1128-1132;

  3. Prox, A.

    1. Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
      T. Ebner, G. Heinzel, A. Prox, K. Beschke and H. Wachsmuth
      Drug Metabolism and Disposition October 1999, 27 (10) 1143-1149;

R

  1. Radominska-Pandya, Anna

    1. Studies on the Substrate Specificity of Human Intestinal UDP-Glucuronosyltransferases 1A8 and 1A10
      Ziqiang Cheng, Anna Radominska-Pandya and Thomas R. Tephly
      Drug Metabolism and Disposition October 1999, 27 (10) 1165-1170;

  2. Ramachandran, Vinod

    1. Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;

  3. Reitz, Beverly

    1. Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;

  4. Ring, Barbara J.

    1. Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;

  5. Rosenborg, Johan

    1. Mass Balance and Metabolism of [3H]Formoterol in Healthy Men after Combined i.v. and Oral Administration–Mimicking Inhalation
      Johan Rosenborg, Per Larsson, Kerstin Tegnér and Gösta Hallström
      Drug Metabolism and Disposition October 1999, 27 (10) 1104-1116;

  6. Roth, Jeri S.

    1. 2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition
      Jeri S. Roth, Cynthia M. McCully, Frank M. Balis, David G. Poplack and James A. Kelley
      Drug Metabolism and Disposition October 1999, 27 (10) 1128-1132;

S

  1. Scarfe, Graeme B.

    1. Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;

  2. Schoenhard, Grant L.

    1. Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;

  3. Shipley, Lisa A.

    1. Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;

  4. Skordos, Konstantine W.

    1. Identification of Phase I Metabolites of 3-Methylindole Produced by Pig Liver Microsomes
      Gonzalo J. Diaz, Konstantine W. Skordos, Garold S. Yost and E. James Squires
      Drug Metabolism and Disposition October 1999, 27 (10) 1150-1156;

  5. Skotland, Tore

    1. Biotransformation of Nonionic X-Ray Contrast Agents In Vivo and In Vitro
      Petter Balke Jacobsen, Åsmund Larsen, Roozbeh Konarboland and Tore Skotland
      Drug Metabolism and Disposition October 1999, 27 (10) 1205-1213;

  6. Squires, E. James

    1. Identification of Phase I Metabolites of 3-Methylindole Produced by Pig Liver Microsomes
      Gonzalo J. Diaz, Konstantine W. Skordos, Garold S. Yost and E. James Squires
      Drug Metabolism and Disposition October 1999, 27 (10) 1150-1156;

  7. Stevenson, David K.

    1. Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

  8. Strom, Stephen C.

    1. Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;

T

  1. Tainaka, Hitoshi

    1. Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

  2. Takaba, Toshihiro

    1. Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

  3. Takahashi, Harumi

    1. Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

  4. Tegnér, Kerstin

    1. Mass Balance and Metabolism of [3H]Formoterol in Healthy Men after Combined i.v. and Oral Administration–Mimicking Inhalation
      Johan Rosenborg, Per Larsson, Kerstin Tegnér and Gösta Hallström
      Drug Metabolism and Disposition October 1999, 27 (10) 1104-1116;

  5. Tephly, Thomas R.

    1. Studies on the Substrate Specificity of Human Intestinal UDP-Glucuronosyltransferases 1A8 and 1A10
      Ziqiang Cheng, Anna Radominska-Pandya and Thomas R. Tephly
      Drug Metabolism and Disposition October 1999, 27 (10) 1165-1170;

V

  1. Venkataramanan, Raman

    1. Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;

  2. Vreman, Hendrik J.

    1. Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

W

  1. Wachsmuth, H.

    1. Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
      T. Ebner, G. Heinzel, A. Prox, K. Beschke and H. Wachsmuth
      Drug Metabolism and Disposition October 1999, 27 (10) 1143-1149;

  2. Wilson, Ian D.

    1. Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;

  3. Wright, Brian

    1. Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;

  4. Wrighton, Steven A.

    1. Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;

Y

  1. Yamazaki, Masayo

    1. Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;

  2. Yan, Bo

    1. Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;

  3. Yasumori, Toshio

    1. Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

  4. Yost, Garold S.

    1. Identification of Phase I Metabolites of 3-Methylindole Produced by Pig Liver Microsomes
      Gonzalo J. Diaz, Konstantine W. Skordos, Garold S. Yost and E. James Squires
      Drug Metabolism and Disposition October 1999, 27 (10) 1150-1156;

Z

  1. Zhang, Qing-Yu

    1. Induction of Rat Small Intestinal Cytochrome P-450 2J4
      Qing-Yu Zhang, Xinxin Ding, Deborah Dunbar, Ling Cao and Laurence S. Kaminsky
      Drug Metabolism and Disposition October 1999, 27 (10) 1123-1127;

  2. Zhang, Shimin

    1. Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;
Back to top

In this issue

Advertisement